×
About 425 results

ALLMedicine™ Tractional Retinal Detachment Center

Research & Reviews  141 results

Ozurdex in Reducing PVR After Vitreotomy in PDR
https://clinicaltrials.gov/ct2/show/NCT05415826

Jun 13th, 2022 - Diabetic retinopathy is a significant source of visual morbidity in the adult population. Complications of diabetic retinopathy include ischemic maculopathy, macular edema, and sequelae of fibrovascular proliferation, such as vitreous hemorrhage (...

Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy
https://clinicaltrials.gov/ct2/show/NCT05414149

Jun 10th, 2022 - Proliferative diabetic retinopathy (PDR) is the most common causes of irreversible blindness in diabetic retinopathy (DR).It is characterized by progressive loss of vision, retinal edema, vitreous hemorrhage (VH), retinal neovascularization, fibro...

Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR
https://clinicaltrials.gov/ct2/show/NCT05408416

Jun 7th, 2022 - Proliferative diabetic retinopathy (PDR) is the most common causes of irreversible blindness in diabetic retinopathy (DR).It is characterized by progressive loss of vision, retinal edema, vitreous hemorrhage (VH), retinal neovascularization, fibro...

see more →

Clinicaltrials.gov  23 results

Ozurdex in Reducing PVR After Vitreotomy in PDR
https://clinicaltrials.gov/ct2/show/NCT05415826

Jun 13th, 2022 - Diabetic retinopathy is a significant source of visual morbidity in the adult population. Complications of diabetic retinopathy include ischemic maculopathy, macular edema, and sequelae of fibrovascular proliferation, such as vitreous hemorrhage (...

Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy
https://clinicaltrials.gov/ct2/show/NCT05414149

Jun 10th, 2022 - Proliferative diabetic retinopathy (PDR) is the most common causes of irreversible blindness in diabetic retinopathy (DR).It is characterized by progressive loss of vision, retinal edema, vitreous hemorrhage (VH), retinal neovascularization, fibro...

Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR
https://clinicaltrials.gov/ct2/show/NCT05408416

Jun 7th, 2022 - Proliferative diabetic retinopathy (PDR) is the most common causes of irreversible blindness in diabetic retinopathy (DR).It is characterized by progressive loss of vision, retinal edema, vitreous hemorrhage (VH), retinal neovascularization, fibro...

Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPV
https://clinicaltrials.gov/ct2/show/NCT02590094

Dec 3rd, 2021 - Severe vision loss in patients with proliferative diabetic retinopathy (PDR) frequently results from complications related to neovascularization and fibrovascular proliferation. Patients with PDR are typically considered candidates for pars plana ...

Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy
https://clinicaltrials.gov/ct2/show/NCT03660384

Dec 2nd, 2021 - Severe vision loss in patients with proliferative diabetic retinopathy (PDR) frequently results from complications related to neovascularization and fibrovascular proliferation. Patients with PDR are typically considered candidates for pars plana ...

see more →

News  6 results

Surgery Equals Drug Treatment for Bleeding in Diabetic Retinopathy
https://www.medscape.com/viewarticle/943374

Dec 30th, 2020 - In the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, intraocular injection with anti–vascular endothelial growth factor (VEGF) shows similar efficacy to that of vitrectomy with photocoagulation; however, patients common...

Statins Cut Retinopathy Risk in Type 2 Diabetes
https://www.medpagetoday.com/primarycare/diabetes/77360?comment=true

Jan 10th, 2019 - Treatment with statins was associated with a significantly decreased risk of diabetic retinopathy in patients with type 2 diabetes and high cholesterol in a large cohort study from Taiwan. Statin therapy was also associated with a lower need for i...

Promising Therapies for Diabetic Eye Disease on the Way: Ophthalmology Times
https://www.medpagetoday.com/ophthalmology/generalophthalmology/68284

Oct 3rd, 2017 - One expert describes promising strategies for treating diabetic eye disease. A recent study provides new insights into how to prevent tractional retinal detachment from developing or progressing in patients with severe proliferative diabetic retin...

Diabetic Youth Don't Get Screened for Eye Complication
https://www.medpagetoday.com/ophthalmology/generalophthalmology/64073

Mar 23rd, 2017 - Action Points Many youths with type 1 and type 2 diabetes are not being screened for diabetic retinopathy in accordance with current guidelines. Note that sociodemographic factors also played a role in screening patterns, with minority youth repor...

A Review of Anti-VEGF Agents for Proliferative Diabetic Retinopathy
https://www.medscape.com/viewarticle/825295

Abstract and Introduction Abstract Previous research has implicated vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic retinopathy (DR). Although many studies reviewed the use of anti-VEGF for diabetic macular oedema, little...

see more →